Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent? | Aplastic Anemia and MDS International Foundation

Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent?

Journal Title: 
Leuk Lymphoma
Primary Author: 
Zeidan AM
Author(s): 
Zeidan AM
Original Publication Date: 
Wednesday, September 27, 2017

No abstract available.

Bone Marrow Diseases: